Spots Global Cancer Trial Database for stereotactic ablative radiotherapy
Every month we try and update this database with for stereotactic ablative radiotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion | NCT01850368 | Hepatocellular ... Portal Vein Tum... | Stereotactic ab... | 20 Years - | Korea Cancer Center Hospital | |
| Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC | NCT04786093 | Non Small Cell ... | Stereotactic ra... Durvalumab | 18 Years - | University of Texas Southwestern Medical Center | |
| Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer | NCT05815927 | Oligometastatic... | Pembrolizumab stereotattic ab... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET) | NCT01446744 | Metastatic Tumo... | Stereotactic ab... palliative radi... | 18 Years - | Lawson Health Research Institute | |
| Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma | NCT05488366 | Sarcoma, Soft T... | Pembrolizumab Radiation thera... | 18 Years - | University of California, Irvine | |
| A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. | NCT05717166 | Metastatic Tumo... | Palliative Radi... Chemotherapy Hormone therapy Immunotherapy Targeted System... Observation Stereotactic Ab... Surgery Radiofrequency ... Fractionated Ra... | 18 Years - | Lawson Health Research Institute | |
| Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion | NCT01850368 | Hepatocellular ... Portal Vein Tum... | Stereotactic ab... | 20 Years - | Korea Cancer Center Hospital | |
| Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer | NCT02417662 | Non-small Cell ... | Radical Radioth... Non-investigati... | 18 Years - | University College, London | |
| Durvalumab (MEDI4736) and Radiosurgery (fSRT vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases | NCT04889066 | Brain Metastase... | Stereotactic Ra... Durvalumab | 18 Years - | University of Texas Southwestern Medical Center | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study | NCT05673148 | Metastatic Colo... Stage IV Colore... | Stereotactic Ab... Resection Microwave Ablat... Chemotherapy Computed Tomogr... Magnetic Resona... Positron Emissi... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy | NCT02357992 | Lung Cancer | Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer | NCT04253483 | Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... | High-Dose Rate ... Quality-of-Life... Questionnaire A... Stereotactic Ab... | 18 Years - | Rutgers, The State University of New Jersey | |
| Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc | NCT06084338 | Prostate Cancer | stereotactic ab... Pluvicto topical testost... | 18 Years - | VA Office of Research and Development | |
| Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma | NCT05224934 | Soft Tissue Sar... Retroperitoneal... Radiotherapy Si... Ultra-hypofract... Stereotactic Ab... | ultra-hypofract... | 18 Years - | ChineseAMS | |
| Radiotherapy for Extracranial Oligometastatic Breast Cancer | NCT04646564 | Breast Cancer M... | standard of car... radiotherapy + ... | 18 Years - 70 Years | ChineseAMS | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm | NCT05555342 | Lung Tumor Metastatic Canc... | Irreversible el... Radiation Thera... | 18 Years - | University of California, Irvine | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic Lymphadenopathy | NCT02803151 | Metastasis of M... | Stereotactic ab... | 20 Years - | National Taiwan University Hospital | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors | NCT03721341 | Metastatic Tumo... | Palliative Radi... Chemotherapy Immunotherapy Hormones Observation Stereotactic Ab... | 18 Years - | Lawson Health Research Institute | |
| HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer | NCT04870567 | Biochemical Rel... Complications R... | Stereotactic ab... High dose rate ... | 18 Years - 90 Years | N.N. Petrov National Medical Research Center of Oncology | |
| Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR) | NCT02958163 | Liver Neoplasms Hepatocellular ... | Trans-arterial ... Doxorubicin Stereotactic Ab... | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET) | NCT01446744 | Metastatic Tumo... | Stereotactic ab... palliative radi... | 18 Years - | Lawson Health Research Institute | |
| Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease | NCT03485378 | Non Small Cell ... Interstitial Lu... | Stereotactic Ab... | 18 Years - | Lawson Health Research Institute | |
| Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma | NCT01850667 | Hepatocellular ... | Stereotactic bo... | 20 Years - | Korea Cancer Center Hospital | |
| Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer | NCT02353819 | Prostate Cancer | Stereotactic Ab... | 18 Years - | University of Texas Southwestern Medical Center | |
| Targeted Radiotherapy for Recurrent Prostate Cancer | NCT05067660 | Prostate Cancer... | Stereotactic ab... Current standar... | 18 Years - | Tampere University Hospital | |
| A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm | NCT05555342 | Lung Tumor Metastatic Canc... | Irreversible el... Radiation Thera... | 18 Years - | University of California, Irvine | |
| Single Versus Multiple Fractionated SSRS for Spinal Metastases | NCT02608866 | Secondary Malig... | SF-SSRS MF-SSRS | 20 Years - | National Taiwan University Hospital | |
| Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment | NCT04852588 | Non-Small Cell ... | Endobronchial u... Transesophageal... | 18 Years - | Lawson Health Research Institute | |
| Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients | NCT06416436 | Solid Tumor | Atezolizumab Stereotactic Ab... | 18 Years - | University of Kansas Medical Center | |
| Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study | NCT05863351 | Metastatic Rena... Stage IV Renal ... | Computed Tomogr... Magnetic Resona... Questionnaire A... Stereotactic Ab... Systemic Therap... | 18 Years - | Eastern Cooperative Oncology Group | |
| Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients | NCT06416436 | Solid Tumor | Atezolizumab Stereotactic Ab... | 18 Years - | University of Kansas Medical Center | |
| Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy | NCT05808790 | Lung Metastases Colorectal Canc... | Minimally invas... Stereotactic ab... | 18 Years - | Amsterdam UMC, location VUmc | |
| Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors | NCT06349837 | Solid Tumor | Tislelizumab Low Dose Radiot... Stereotactic Ab... | 18 Years - | Sichuan University | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer | NCT03862911 | Metastatic Tumo... | palliative radi... Stereotactic ab... | 18 Years - | British Columbia Cancer Agency | |
| Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc | NCT06084338 | Prostate Cancer | stereotactic ab... Pluvicto topical testost... | 18 Years - | VA Office of Research and Development | |
| Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study | NCT05673148 | Metastatic Colo... Stage IV Colore... | Stereotactic Ab... Resection Microwave Ablat... Chemotherapy Computed Tomogr... Magnetic Resona... Positron Emissi... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease | NCT06356779 | Oligometastatic... Metastases Ablation Techni... Radiotherapy Stereotactic Ra... Surgery | Local ablative ... | 18 Years - | Herlev Hospital | |
| Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma | NCT05488366 | Sarcoma, Soft T... | Pembrolizumab Radiation thera... | 18 Years - | University of California, Irvine | |
| Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study | NCT05327686 | Metastatic Rena... Stage III Renal... Stage IV Renal ... Unresectable Re... | Avelumab Axitinib Cabozantinib Ipilimumab Lenvatinib Nivolumab Pembrolizumab Stereotactic Ab... | 18 Years - | NRG Oncology | |
| Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc | NCT06084338 | Prostate Cancer | stereotactic ab... Pluvicto topical testost... | 18 Years - | VA Office of Research and Development | |
| Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study | NCT05327686 | Metastatic Rena... Stage III Renal... Stage IV Renal ... Unresectable Re... | Avelumab Axitinib Cabozantinib Ipilimumab Lenvatinib Nivolumab Pembrolizumab Stereotactic Ab... | 18 Years - | NRG Oncology | |
| Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR) | NCT02958163 | Liver Neoplasms Hepatocellular ... | Trans-arterial ... Doxorubicin Stereotactic Ab... | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer | NCT04870567 | Biochemical Rel... Complications R... | Stereotactic ab... High dose rate ... | 18 Years - 90 Years | N.N. Petrov National Medical Research Center of Oncology | |
| Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study | NCT05863351 | Metastatic Rena... Stage IV Renal ... | Computed Tomogr... Magnetic Resona... Questionnaire A... Stereotactic Ab... Systemic Therap... | 18 Years - | Eastern Cooperative Oncology Group | |
| HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer | NCT04870567 | Biochemical Rel... Complications R... | Stereotactic ab... High dose rate ... | 18 Years - 90 Years | N.N. Petrov National Medical Research Center of Oncology | |
| Evaluating Changes in Quality of Life After Near Margin-less Adaptive Radiation Therapy Compared to Standard Stereotactic Ablative Body Radiotherapy in Localized Prostate Cancer | NCT06325046 | Localized Prost... Stage I Prostat... Stage II Prosta... Stage III Prost... | Computed Tomogr... Cone-Beam Compu... Image-Guided Ad... Magnetic Resona... Stereotactic Ab... Survey Administ... | 18 Years - | Mayo Clinic | |
| Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer | NCT02353819 | Prostate Cancer | Stereotactic Ab... | 18 Years - | University of Texas Southwestern Medical Center | |
| Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR) | NCT02958163 | Liver Neoplasms Hepatocellular ... | Trans-arterial ... Doxorubicin Stereotactic Ab... | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients | NCT05265663 | Pancreatic Canc... | stereotactic ab... | 18 Years - | Amsterdam UMC, location VUmc | |
| Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT) | NCT02594072 | Prostate Cancer | stereotactic ab... external beam r... Zoladex ® | - | University of British Columbia | |
| Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy | NCT02357992 | Lung Cancer | Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
